ScinoPharm Taiwan Χρέος 2025

Τι κάνει η ScinoPharm Taiwan;

ScinoPharm Taiwan Ltd is a leading company specializing in the development and manufacturing of pharmaceutical active ingredients. It was founded in 1997 and is headquartered in Taichung City, Taiwan. The founders of ScinoPharm have brought their expertise from the chemical and pharmaceutical industries, as well as the academic world, into the company. ScinoPharm has established itself as a strong partner for the development and production of API's (Active Pharmaceutical Ingredients) in the pharmaceutical industry. ScinoPharm's business model is based on high-quality and reliable production, combined with research and development and complementary distribution capabilities. ScinoPharm has taken a leading role in all areas of the pharmaceutical industry and has become a key player in the global supply chain. ScinoPharm specializes in the development and manufacturing of non-patented generic API's and specialty chemicals used in the production of generics. The company is able to safely and efficiently manufacture a wide range of API's, such as antibiotics, antidepressants, antihypertensives, or antiepileptics. ScinoPharm has also specialized in the production of high-potency products (hormones, cytostatics) and custom synthesis services. The custom synthesis service allows customers to obtain specific compounds in the shortest possible time. ScinoPharm's business model goes beyond production and includes a comprehensive research and development component. The company has a dedicated and experienced team of chemists and pharmacists and has made substantial investments in research and development to meet the demands and needs of customers and the industry. ScinoPharm has also formed partnerships with some of the world's leading pharmaceutical companies to develop and bring innovative active ingredients to market. ScinoPharm is divided into several divisions, including Generics, HPAPIs, Custom Synthesis, China Sales, and Licensing & Polymers. The Generics division produces generic API's including antibiotics, antidepressants, antihypertensives, and antiepileptics. The HPAPIs division focuses on the production of high-potency products, such as steroid hormones, peptides, and cytostatics. The Custom Synthesis division creates specific compounds in the shortest possible time. The "China Sales" division deals with the sale of products in China through affiliated companies, while the "Licensing & Polymers" division focuses on the development and sale of polymer compatibility, which is an innovative material to support medical devices. In summary, ScinoPharm is a key player in the global supply chain of the pharmaceutical industry. The company has established itself as a strong partner for API manufacturing, the development of innovative active ingredients, and supporting customers in the industry. ScinoPharm places great importance on its research and development component and invests in an experienced team of chemists and pharmacists. The various divisions of ScinoPharm, including Generics, HPAPIs, Custom Synthesis, China Sales, and Licensing & Polymers, offer a wide range of products and services tailored to the specific needs of customers. ScinoPharm Taiwan ist eines der beliebtesten Unternehmen auf Eulerpool.com.